Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase

Tetrahedron

Volumn 52, Issue 39, 1996, Pages 12651-12666

  Cui, Cheng Bin ^a   Kakeya, Hideaki ^a   Osada, Hiroyuki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; SPIROTRYPROSTATIN A; SPIROTRYPROSTATIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASPERGILLUS FUMIGATUS; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION; INFRARED SPECTROPHOTOMETRY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALIA; ASPERGILLUS FUMIGATUS; MAMMALIA;

EID: 0030599282     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(96)00737-5     Document Type: Article

References (24)

1. 1. A part of this work was reported in our preliminary communication. C.-B. Cui, H. Kakeya and H. Osada, J. Antibiot., 1996, 49 (8), in press.
2. 2. J. A. Cooper and B. Howell, Cell, 1993, 73, 1051-1054.
3. 3. R. A. Weinberg, Science, 1991, 254, 1138-1146.
4. 4. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts and, J. D. Watson, Molecular Biology of the Cell; Second Edition, Glarland Publishing, Inc.: New York, 1989; pp. 752, pp. 1199 and pp. 1203.
5. 5. H. Osada, C.-B. Cui, R. Onose and F. Hanaoka, Bioorg. Med. Chem., 1996, in press.
6. 6. C.-B. Cui, H. Kakeya, G. Okada, R. Onose, M Ubukata, I. Takahashi, K. Isono and H. Osada, J. Antibiot., 1995, 48, 1382-1384.
7. 7. C.-B. Cui, M. Ubukata, H. Kakeya, R. Onose, G. Okada, I. Takahashi, K. Isono and H. Osada, J. Antibiot., 1996, 49, 216-219.
8. 8. C.-B. Cui, H. Kakeya, G. Okada, R. Onose and H. Osada, J. Antibiot., 1996, 49, 527-533.
9. 9. C.-B. Cui, H. Kakeya and H. Osada, J. Antibiot., 1996, 49, 534-540.
10. 10. C. N. R. Rao, Chemical Applications of Infrared Spectroscopy; Academic Press Inc.: New York, 1963; pp. 258-261.
11. 13C NMR signal patterns comparing with those of 1. For instance, two amide carbonyl carbons in the diketopiperazine part in 2 appeared in the markedly high field region (δ162.60, C-11 and δ155.09, C-17) than the corresponding carbons in 1 (Table 2), tryprostatins and related diketopiperazine alkaloids (cf. reference 9).
12. 12. a) S. Takeuchi, J. Uzawa, H. Seto and H. Yonehara, Tetrahedron Lett., 1977, 2943-2946.
13. b) H. Seto, T., Sasaki, H. Yonehara and J. Uzawa, Tetrahedron Lett., 1978, 923-926.
14. c) H. Seto, N. Otake, M. Koyama, H. Ogino, Y. Kodama, N. Nishizawa, T. Tsuruoka and S. Inoue, Tetrahedron Lett., 1983, 24, 495-498.
15. 13. a) C.-B. Cui, Y. Tezuka, T. Kikuchi, H. Nakano, T. Tamaoki and, J.-H. Park, Chem. Pharm. Bull., 1992, 40, 2035-2040.
16. b) H.-O. Kalinowski, S. Berger and S. Bran, Carbon-13 NMR Spectroscopy; John Wiley and Sons: New York, 1988; pp. 543.
17. c) H. Seto, K. Furihata, N. Otake, Y. Itoh, S. Takahashi, T. Haneishi and M. Ohuichi, Tetrahedron Lett., 1984, 25, 337-340.
18. CH coupling constant of the C-8 methine group.
19. 15. a) P. S. Steyn, Tetrahedron, 1973, 29, 107-120.
20. b) P. S. Steyn, Tetrahedron Lett., 1971, 3331-3334.
21. c) A. J. Brich and J. J. Wright, Tetrahedron, 1970, 26, 2329-2344.
22. d) R. M. Williams, E. K. H. Coffman and T. Glinka, J. Am. Chem. Soc., 1989, 111, 3064-3065.
23. 16. P. S. Steyn and R. Vleggaar, Progress in the Chemistry of Organic Natural Products (Founded by L. Zechmiester, Edited by W. Herz, H. Grisebach and G. W. Kirby). 1985, 48, 1-80.
24. 9 positions between 1 and 2 might be involved except for the effect of methoxy group in 1.